These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Can I stop my PCP prophylaxis? Gaylord G Posit Living; 1999 Mar; 8(2):22. PubMed ID: 12492001 [No Abstract] [Full Text] [Related]
24. [When and how should primary prevention against Pneumocystis carinii pneumonia be carried out in HIV infection?]. Eeftinck Schattenkerk JK; Hoepelman IM Ned Tijdschr Geneeskd; 1990 Aug; 134(33):1579-81. PubMed ID: 1975648 [No Abstract] [Full Text] [Related]
25. Editorial response: Prophylaxis for Pneumocystis carinii pneumonia--an evolving tale of two populations. Gaut P; Daar ES Clin Infect Dis; 1999 Oct; 29(4):784-6. PubMed ID: 10589888 [No Abstract] [Full Text] [Related]
26. Impact of primary prophylaxis for Pneumocystis carinii pneumonia and toxoplasmic encephalitis in a cohort of 1000 patients with AIDS. Monforte AD; Mainini F; Bini T; Moscatelli GC; Antinori S; Formenti T; Testa L; Mena M; Moroni M J Chemother; 1995 Nov; 7 Suppl 4():184-6. PubMed ID: 8904150 [No Abstract] [Full Text] [Related]
27. [Incidence of bacterial pneumonia in HIV-positive patients treated with preventive co-trimoxazole or pentamidine]. Koch A; Kothe H; Braun J; Kämmerer R; Friedrich HJ; Dalhoff K Pneumologie; 1998 Nov; 52(11):614-21. PubMed ID: 9885511 [TBL] [Abstract][Full Text] [Related]
28. [Withdrawal of Pneumocystis carinii pneumonia prophylaxis in patients receiving efficacious combined antiretroviral treatment. Study of 85 cases]. García Vázquez E; de Górgolas Hernández M; García Delgado R; Fernández Guerrero ML Med Clin (Barc); 1999 Jun; 113(3):89-90. PubMed ID: 10464742 [TBL] [Abstract][Full Text] [Related]
29. Cotrimoxazole prophylaxis for infants exposed to HIV infection. Graham SM Bull World Health Organ; 2004 Apr; 82(4):297-8. PubMed ID: 15259259 [No Abstract] [Full Text] [Related]
30. Recommendations for prophylaxis against Pneumocystis carinii pneumonia for persons infected with human immunodeficiency virus. U.S. Public Health Service Task Force on Antipneumocystis Prophylaxis in Patients with Human Immunodeficiency Virus Infection. J Acquir Immune Defic Syndr (1988); 1993 Jan; 6(1):46-55. PubMed ID: 8417174 [No Abstract] [Full Text] [Related]
32. Protect yourself from Pneumocystis carinii. AIDS Alert; 1999 Jun; 14(6):suppl 1-2. PubMed ID: 11366414 [TBL] [Abstract][Full Text] [Related]
33. Treatment of Pneumocystis carinii pneumonia in adults with AIDS. Deresinski SC Semin Respir Infect; 1997 Jun; 12(2):79-97. PubMed ID: 9195673 [TBL] [Abstract][Full Text] [Related]
34. Atovaquone suspension compared with aerosolized pentamidine for prevention of Pneumocystis carinii pneumonia in human immunodeficiency virus-infected subjects intolerant of trimethoprim or sulfonamides. Chan C; Montaner J; Lefebvre EA; Morey G; Dohn M; McIvor RA; Scott J; Marina R; Caldwell P J Infect Dis; 1999 Aug; 180(2):369-76. PubMed ID: 10395851 [TBL] [Abstract][Full Text] [Related]
35. Aerosolized pentamidine for prevention of Pneumocystis pneumonia after allogeneic marrow transplantation. Przepiorka D; Selvaggi K; Rosenzweig PQ; Borochovitz D; Taylor D Bone Marrow Transplant; 1991 Apr; 7(4):324-5. PubMed ID: 1906356 [No Abstract] [Full Text] [Related]
36. A randomized trial of daily and thrice-weekly trimethoprim-sulfamethoxazole for the prevention of Pneumocystis carinii pneumonia in human immunodeficiency virus-infected persons. Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA). El-Sadr WM; Luskin-Hawk R; Yurik TM; Walker J; Abrams D; John SL; Sherer R; Crane L; Labriola A; Caras S; Pulling C; Hafner R Clin Infect Dis; 1999 Oct; 29(4):775-83. PubMed ID: 10589887 [TBL] [Abstract][Full Text] [Related]
38. Provisional WHO/UNAIDS recommendations on the use of contrimoxazole prophylaxis in adults and children living with HIV/AIDS in Africa. ; Afr Health Sci; 2001 Aug; 1(1):30-1. PubMed ID: 12833907 [No Abstract] [Full Text] [Related]
39. Is it necessary to conduct trials with trimethoprim-sulphamethoxazole amongst HIV-infected individuals in Africa? Samb B; Badiane M; Kony S; Larouzé B; Faye MA; Sow PS; Badiane S; Metro A; Costagliola D; Ndoye I; Delaporte E; Coll-Seck AM; Coulaud JP AIDS; 1998 Mar; 12(4):447. PubMed ID: 9520181 [No Abstract] [Full Text] [Related]